引用本文:刘静1,林谦2.中药干预经皮冠状动脉介入术后的循证研究进展[J].世界中医药,2017,(02):. |
|
中药干预经皮冠状动脉介入术后的循证研究进展 |
Review of Evidence-based Studies Applying Chinese Herbs for Prevention and Treatment on Challenges Facing by Percutaneous Coronary Intervention |
投稿时间:2016-03-29 |
DOI:10.3969/j.issn.1673-7202.2017.02.051 |
中文关键词: 经皮冠状动脉介入术 中药 循证医学 综述 |
English Keywords:PCI Chinese herbs Evidence-based medicine Review |
基金项目:国家自然科学基金面上项目(编号:81173176)——“基于心肌细胞钙转运-触发活动研究益气法对心衰室性心律失常的干预机制” |
|
摘要点击次数: 789 |
全文下载次数: 877 |
中文摘要: |
经皮冠状动脉介入术开展以来,面临着术后再狭窄、无复流、晚期血栓形成、围手术期心肌损伤等挑战,近年来许多大型循证研究结果肯定了中药在干预这些问题方面的疗效与优势,本文对此作一综述。 |
English Summary: |
The challenges including restenosis,no-reflow phenomenon,late thrombosis and perioperative myocardial injury have been facing by doctors since the application of PCI.However,in recent years,many evidence-based studies have been conducted and confirmed the effects of Chinese herbs in disease prevention and solving the challenges to some extent.This review aims to summarize and review latest studies. |
查看全文 查看/发表评论 下载PDF阅读器 |